In our study, the overall methylation frequency for CDKN2A/p16 was low in both invasive high grade (24%) and non-invasive low grade (19%) urothelial bladder cancer with a very low normalized index of methylation. The gene discussed is CDKN2A; the disease is bladder transitional cell carcinoma.